Sign In
Buy TLSA
$1.18
-0.180 (-13.24%)
At Close: Jun 03, 2026
NEW YORK and LONDON, May 05, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeut
Tiziana Life Sciences says Accustem Sciences business will be spin out on Nasdaq
08:45am, Tuesday, 13'th Apr 2021
Tiziana Life Sciences PLC (NASDAQ:TLSA, LON:TILS) said it plans to list its diagnostics business Accustem Sciences on the Nasdaq stock market in the US after its demerger and the distribution of new s
Tiziana Life says breast cancer prognostic business Accustem Sciences to list on Nasdaq
08:41am, Tuesday, 13'th Apr 2021
Tiziana Life Sciences plc (LON:TILS NASDAQ:TLSA) said its former subsidiary, Accustem Sciences Limited intends to list on Nasdaq. The listing will follow shortly after the completion of the distributi
Tiziana Life says breast cancer diagnostic business Accustem Sciences to list on Nasdaq
08:39am, Tuesday, 13'th Apr 2021
Tiziana Life Sciences plc (LON:TILS NASDAQ:TLSA) said its former subsidiary, Accustem Sciences Limited intends to list on Nasdaq. The listing will follow shortly after the completion of the distributi
Zacks Small-Cap Research has started coverage on drug developer Tiziana Life Sciences PLC (NASDAQ:TLSA) (LON:TILS), which is advancing three candidates for a variety of indications in autoimmune disea
Tiziana Life Sciences: US investment bank restates its US$8 price and 'buy' recommendation after double dose of good news
12:26pm, Tuesday, 30'th Mar 2021
US investment bank B. Riley Financial has reiterated its ‘buy' advice and US$8 a share price target for Tiziana Life Sciences (NASDAQ:TLSA, LON:TILS) after a double dose of good news.
Shares in Tiziana Life Sciences plc (NASDAQ:TLSA, LON:TILS) shot up 20% after it announced the US regulator has approved the use of its nasally administered monoclonal antibody to treat a person with
TLSA Stock Price Increased Over 10% Pre-Market: Why It Happened
08:46am, Tuesday, 30'th Mar 2021
The stock price of Tiziana Life Sciences plc (NASDAQ: TLSA) has increased by over 10% pre-market. This is why it happened.
Tiziana Life Sciences plc: Accustem Update
07:35am, Tuesday, 30'th Mar 2021
NEW YORK and LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences. (NASDAQ: TLSA; LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and inf
Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients
03:15am, Tuesday, 30'th Mar 2021
Tiziana Life Sciences PLC (NASDAQ:TLSA, LON:TILS) is taking its nasally-administered monoclonal antibody (mAB) into phase II clinical trials in people with moderate to severe Coronavirus (COVID-19). T
Tiziana Life Sciences planning phase II clinical trial of monoclonal antibody treatment in patients with moderate to severe COVID-19
02:48am, Tuesday, 30'th Mar 2021
Tiziana Life Sciences PLC (NASDAQ:TLSA, LON:TILS) is taking its nasally-administered monoclonal antibody (mAB) into phase II clinical trials in people with moderate to severe COVID-19. This follows an
NEW YORK and LONDON, March 29, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (NASDAQ: TLSA; LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infe
NEW YORK and LONDON, March 29, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences. (NASDAQ: TLSA; LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and inf
Tiziana Life Sciences Interview to Air on Bloomberg Television US on The RedChip Money Report
02:00am, Friday, 26'th Feb 2021
NEW YORK and LONDON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (NASDAQ: TLSA; LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infe
Tiziana Life Sciences to present at BIO CEO & Investor online conference
11:02am, Tuesday, 16'th Feb 2021
Tiziana Life Sciences PLC (LON:TILS, NASDAQ:TLSA) said it is presenting at the BIO CEO & Investor Digital Conference. The conference starts today and runs until Thursday.
